Replies to post #547265 on $Stock*Shop*Charts*News*Option$

[Tuff-Stuff]

PDUFA date approaches for CE Melphalan NDA

The PDUFA date for Ligand Pharmaceutical's (LGND) CE Melphalan is Tuesday, September 30. The NDA was submitted by development and commercial partner Spectrum Pharmaceuticals (SPPI -0.9%).
Captisol-enabled Melphalan is free of propylene glycol, which is associated with renal and cardiac side effects.
Melphalan is a myeloablative therapy that is used prior to autologous stem cell transplantation

[Tuff-Stuff]

Getting ugly here....